Core Insights - Investing in emerging technologies is characterized by high volatility and unpredictability, with companies often trading on potential rather than current results [2][3] - A diversified portfolio may benefit from small positions in promising emerging tech stocks, which can provide exposure to significant long-term trends such as AI, robotics, and electric air mobility [3] Company Highlights - **Navitas Semiconductor (NASDAQ: NVTS)** focuses on designing gallium nitride (GaN) and silicon carbide (SiC) power semiconductors for AI data centers, addressing power delivery challenges as data centers scale for demanding AI workloads [5] - The partnership with Nvidia for the next-generation 800-volt HVDC data center architecture has led to an 83.5% increase in shares in the first half of 2025, although Navitas generated only $83.3 million in revenue for full-year 2024 and remains unprofitable [7][8] - Chris Allexandre was appointed CEO in September 2025 to help scale commercial production, leveraging his experience in the semiconductor industry [8] - **SS Innovations International (NASDAQ: SSII)** is developing surgical robotic systems aimed at making advanced procedures more affordable and accessible globally, with an installed base of 125 units across six countries as of September 30, 2025 [11] - The company plans to submit its surgical robotic system to the FDA in Q4 2025 after completing validation studies at Johns Hopkins Hospital [10]

The program was led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, a leading figure in thyroid ablation and endocrine surgery. He was joined by Dr. Gregory Randolph, Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School and the Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology. Visiting Tulane as a Distinguished Professor on May 9, 2025, Dr. Randolph engaged in academic discussions with Dr. Kandil on a range of ...

Core Insights - Baird Medical is advancing minimally invasive thyroid therapies through specialized training programs and collaboration with medical leaders [3][4] - Dr. Shahzad Ahmad, a prominent endocrinologist, completed training in microwave ablation (MWA) techniques, enhancing his clinical skills [2][4] - The company aims to improve patient outcomes with innovative surgical technologies and has established a strong presence in the U.S. and China [4] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatments, focusing on surgical robotic systems and advanced surgical instruments [4] - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics across the U.S. [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries [4]